Identification of angiotensin II receptor subtypes von Chiu, Andrew T., Herblin, William F., McCall, Dale E., Ardecky, Robert J., Carini, David J., Duncia, John V., Pease, Lori J., Wong, Pancras C., Wexler, Ruth R., Johnson, Alexander L., Timmermans, Pieter B.M.W.M.

Volltext

S 1 heterocyclic thrombin inhibitors von Dominguez, C, Carini, D.J, Weber, P.C, Knabb, R.M, Alexander, R.S, Kettner, C.A, Wexler, R.R

Volltext

S1 heterocyclic thrombin inhibitors von DOMINGUEZ, C, CARINI, D. J, WEBER, P. C, KNABB, R. M, ALEXANDER, R. S, KETTNER, C. A, WEXLER, R. R

Volltext

Angiotensin II Receptor Heterogeneity von Herblin, William F., Chiu, Andrew T., McCall, Dale E., Ardecky, Robert J., Carini, David J., Duncia, John V., Pease, Lori J., Wong, Pancras C., Wexler, Ruth R., Johnson, Alexander L, Timmermans, Pieter B.M.W.M.

Volltext

Nonpeptide angiotensin II (AII) receptor antagonists: DMP 811, a 20-fold more potent orally-active antihypertensive agent than losartan (DUP 753) von Wong, P.C., Chiu, A.T., Ardecky, R.J., Carini, D.J., Wexler, R.R., Smith, R.D., Timmermans, P.B.M.W.M.

Volltext

5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents von D.A. NUGIEL, E.W. YUE, D.J. CARINI

Volltext bestellen

Pharmacology of an active metabolite of DuP 753 — an orally-active nonpeptide angiotensin II receptor antagonist von Timmermans, P.B.M.W.M., Wong, P.C., Price, W.A., Chiu, A.T., Duncia, J.V., Carini, D.J., Wexler, R.R., Johnson, A.L.

Volltext

DNA recovery of a gallstone in an action for damages von Bozzo, W.R., Carini, G., Pilili, J.P., Mirson, D.J., Lojo, M.M.

Volltext